Prevalence and characteristics of adverse drug events in Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng por |
Título da fonte: | Cadernos de Saúde Pública |
Texto Completo: | https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759 |
Resumo: | The aim of this study was to describe the prevalence of adverse drug events (ADEs) and associated factors reported by users of medicines in Brazil. This was a cross-sectional population-based study conducted from September 2013 to February 2014 with data from the Brazilian National Survey on Access, Use, and Promotion of Rational Use of Medicines (PNAUM). The study included all individuals that reported the use of medicines and identified, among them, all those reporting at least one problem with the medicine’s use. A descriptive analysis was performed to estimate ADE prevalence and 95% confidence intervals (95%CI) among the target variables. Crude and adjusted prevalence ratios were calculated using Poisson regression to investigate factors associated with ADEs. Overall ADE prevalence in Brazil was 6.6% (95%CI: 5.89-7.41), and after multivariate analysis, higher prevalence was associated with female gender, residence in the Central and Northeast regions, consumption of more medicines, “bad” self-rated health, and self-medication. The drugs most frequently reported with ADEs were fluoxetine, diclofenac, and amitriptyline. The most frequent ADEs were somnolence, epigastric pain, and nausea. Most reported ADEs were mild, avoidable, and associated with medicines used frequently by the population. The study provided knowledge on the size of the problem with use of medicines in Brazil. |
id |
FIOCRUZ-5_a536c6a99ed07d6f67ad6350800c1cb4 |
---|---|
oai_identifier_str |
oai:ojs.teste-cadernos.ensp.fiocruz.br:article/6759 |
network_acronym_str |
FIOCRUZ-5 |
network_name_str |
Cadernos de Saúde Pública |
repository_id_str |
|
spelling |
Prevalence and characteristics of adverse drug events in BrazilPrevalência e características dos eventos adversos a medicamentos no BrasilDrug UtilizationDrug-Related Side Effects and Adverse ReactionsPharmacovigilanceHealth SurveysUso de MedicamentosEfeitos Colaterais e Reações Adversas Relacionados a MedicamentosFarmacovigilânciaInquéritos EpidemiológicosThe aim of this study was to describe the prevalence of adverse drug events (ADEs) and associated factors reported by users of medicines in Brazil. This was a cross-sectional population-based study conducted from September 2013 to February 2014 with data from the Brazilian National Survey on Access, Use, and Promotion of Rational Use of Medicines (PNAUM). The study included all individuals that reported the use of medicines and identified, among them, all those reporting at least one problem with the medicine’s use. A descriptive analysis was performed to estimate ADE prevalence and 95% confidence intervals (95%CI) among the target variables. Crude and adjusted prevalence ratios were calculated using Poisson regression to investigate factors associated with ADEs. Overall ADE prevalence in Brazil was 6.6% (95%CI: 5.89-7.41), and after multivariate analysis, higher prevalence was associated with female gender, residence in the Central and Northeast regions, consumption of more medicines, “bad” self-rated health, and self-medication. The drugs most frequently reported with ADEs were fluoxetine, diclofenac, and amitriptyline. The most frequent ADEs were somnolence, epigastric pain, and nausea. Most reported ADEs were mild, avoidable, and associated with medicines used frequently by the population. The study provided knowledge on the size of the problem with use of medicines in Brazil.El presente trabajo tiene como objetivo describir la prevalencia y factores asociados a eventos adversos con medicamentos (EAM), informados por usuarios de medicamentos en Brasil. Se trata de un estudio transversal de base poblacional, realizado durante el período de septiembre de 2013 a febrero de 2014, con datos recogidos en la Encuesta Nacional sobre el Acceso, Utilización y Promoción del Uso Racional de Medicamentos en Brasil (PNAUM). Se consideraron a todas las personas que informaron del uso de medicamentos; entre ellas, se identificaron a las que informaron de por lo menos un problema con el uso del medicamento. Se realizó un análisis descriptivo para estimar la prevalencia y los intervalos de confianza a 95% (IC95%) de EAM entre las variables estudiadas, y se calcularon las razones de prevalencia bruta y ajustada, por la regresión de Poisson, en la investigación de los factores asociados a los EAM. La prevalencia de EAM en Brasil fue de un 6,6% (IC95%: 5,89-7,41), siendo mayor y estadísticamente significante tras la realización del análisis multivariado, entre personas del sexo femenino; residentes en las regiones Centro-Oeste y Nordeste; que consumían un mayor número de medicamentos; que percibían su estado de salud como “malo”; y que se automedicaban. Se informaron de más EAM en medicamentos como: fluoxetina, diclofenaco y amitriptilina. Los EAM más referidos por los entrevistados fueron somnolencia, dolor epigástrico y náuseas. Los EAM más referidos por los entrevistados fueron de naturaleza leve, considerados evitables y estuvieron asociados a medicamentos de uso frecuente por la población. Con motivo de este estudio, fue posible conocer la dimensión del problema ocasionado por el uso de medicamentos en Brasil.O presente trabalho tem como objetivo descrever a prevalência e fatores associados a eventos adversos a medicamentos (EAM) referidos por usuários de medicamentos no Brasil. Trata-se de um estudo transversal de base populacional, realizado no período de setembro de 2013 a fevereiro de 2014, com dados coletados na Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM). Foram consideradas todas as pessoas que referiram o uso de medicamentos; entre elas, foram identificadas as que referiram pelo menos um problema com o uso do medicamento. Realizou-se uma análise descritiva para estimar a prevalência e os intervalos de 95% de confiança (IC95%) de EAM entre as variáveis estudadas, e foram calculadas as razões de prevalência bruta e ajustada, pela regressão de Poisson, na investigação dos fatores associados aos EAM. A prevalência de EAM no Brasil foi de 6,6% (IC95%: 5,89-7,41), sendo maior e estatisticamente significante após a realização da análise multivariada, entre pessoas do sexo feminino; residentes nas regiões Centro-oeste e Nordeste; que consumiam maior número de medicamentos; que percebiam seu estado de saúde como “ruim”; e que se automedicavam. Os EAM foram mais relatados para os medicamentos fluoxetina, diclofenaco e amitriptilina. Os EAM mais referidos pelos entrevistados foram sonolência, dor epigástrica e náuseas. Os EAM mais referidos pelos entrevistados foram de natureza leve, considerados evitáveis e estiveram associados a medicamentos de uso frequente pela população. Em razão desse estudo, foi possível conhecer a dimensão do problema ocasionado pelo uso de medicamentos no Brasil.Reports in Public HealthCadernos de Saúde Pública2018-03-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmltext/htmlapplication/pdfapplication/pdfhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759Reports in Public Health; Vol. 34 No. 4 (2018): AprilCadernos de Saúde Pública; v. 34 n. 4 (2018): Abril1678-44640102-311Xreponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZengporhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14586https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14587https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14588https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14589Livia Alves Oliveira de SousaMarta Maria de França FontelesMirian Parente MonteiroSotero Serrate MengueAndréa Dâmaso BertoldiTatiane da Silva Dal PizzolNoemia Urruth Leão TavaresMaria Auxiliadora OliveiraVera Lucia LuizaLuiz Roberto RamosMareni Rocha FariasPaulo Sergio Dourado Arraisinfo:eu-repo/semantics/openAccess2024-03-06T15:29:31Zoai:ojs.teste-cadernos.ensp.fiocruz.br:article/6759Revistahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csphttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/oaicadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2024-03-06T13:07:43.822293Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)true |
dc.title.none.fl_str_mv |
Prevalence and characteristics of adverse drug events in Brazil Prevalência e características dos eventos adversos a medicamentos no Brasil |
title |
Prevalence and characteristics of adverse drug events in Brazil |
spellingShingle |
Prevalence and characteristics of adverse drug events in Brazil Livia Alves Oliveira de Sousa Drug Utilization Drug-Related Side Effects and Adverse Reactions Pharmacovigilance Health Surveys Uso de Medicamentos Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Farmacovigilância Inquéritos Epidemiológicos |
title_short |
Prevalence and characteristics of adverse drug events in Brazil |
title_full |
Prevalence and characteristics of adverse drug events in Brazil |
title_fullStr |
Prevalence and characteristics of adverse drug events in Brazil |
title_full_unstemmed |
Prevalence and characteristics of adverse drug events in Brazil |
title_sort |
Prevalence and characteristics of adverse drug events in Brazil |
author |
Livia Alves Oliveira de Sousa |
author_facet |
Livia Alves Oliveira de Sousa Marta Maria de França Fonteles Mirian Parente Monteiro Sotero Serrate Mengue Andréa Dâmaso Bertoldi Tatiane da Silva Dal Pizzol Noemia Urruth Leão Tavares Maria Auxiliadora Oliveira Vera Lucia Luiza Luiz Roberto Ramos Mareni Rocha Farias Paulo Sergio Dourado Arrais |
author_role |
author |
author2 |
Marta Maria de França Fonteles Mirian Parente Monteiro Sotero Serrate Mengue Andréa Dâmaso Bertoldi Tatiane da Silva Dal Pizzol Noemia Urruth Leão Tavares Maria Auxiliadora Oliveira Vera Lucia Luiza Luiz Roberto Ramos Mareni Rocha Farias Paulo Sergio Dourado Arrais |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Livia Alves Oliveira de Sousa Marta Maria de França Fonteles Mirian Parente Monteiro Sotero Serrate Mengue Andréa Dâmaso Bertoldi Tatiane da Silva Dal Pizzol Noemia Urruth Leão Tavares Maria Auxiliadora Oliveira Vera Lucia Luiza Luiz Roberto Ramos Mareni Rocha Farias Paulo Sergio Dourado Arrais |
dc.subject.por.fl_str_mv |
Drug Utilization Drug-Related Side Effects and Adverse Reactions Pharmacovigilance Health Surveys Uso de Medicamentos Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Farmacovigilância Inquéritos Epidemiológicos |
topic |
Drug Utilization Drug-Related Side Effects and Adverse Reactions Pharmacovigilance Health Surveys Uso de Medicamentos Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Farmacovigilância Inquéritos Epidemiológicos |
description |
The aim of this study was to describe the prevalence of adverse drug events (ADEs) and associated factors reported by users of medicines in Brazil. This was a cross-sectional population-based study conducted from September 2013 to February 2014 with data from the Brazilian National Survey on Access, Use, and Promotion of Rational Use of Medicines (PNAUM). The study included all individuals that reported the use of medicines and identified, among them, all those reporting at least one problem with the medicine’s use. A descriptive analysis was performed to estimate ADE prevalence and 95% confidence intervals (95%CI) among the target variables. Crude and adjusted prevalence ratios were calculated using Poisson regression to investigate factors associated with ADEs. Overall ADE prevalence in Brazil was 6.6% (95%CI: 5.89-7.41), and after multivariate analysis, higher prevalence was associated with female gender, residence in the Central and Northeast regions, consumption of more medicines, “bad” self-rated health, and self-medication. The drugs most frequently reported with ADEs were fluoxetine, diclofenac, and amitriptyline. The most frequent ADEs were somnolence, epigastric pain, and nausea. Most reported ADEs were mild, avoidable, and associated with medicines used frequently by the population. The study provided knowledge on the size of the problem with use of medicines in Brazil. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-03-29 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759 |
url |
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759 |
dc.language.iso.fl_str_mv |
eng por |
language |
eng por |
dc.relation.none.fl_str_mv |
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14586 https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14587 https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14588 https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6759/14589 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html text/html application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Reports in Public Health Cadernos de Saúde Pública |
publisher.none.fl_str_mv |
Reports in Public Health Cadernos de Saúde Pública |
dc.source.none.fl_str_mv |
Reports in Public Health; Vol. 34 No. 4 (2018): April Cadernos de Saúde Pública; v. 34 n. 4 (2018): Abril 1678-4464 0102-311X reponame:Cadernos de Saúde Pública instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Cadernos de Saúde Pública |
collection |
Cadernos de Saúde Pública |
repository.name.fl_str_mv |
Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br |
_version_ |
1798943386702446592 |